{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:07:09Z","timestamp":1793304429838,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-12384-x","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T16:55:44Z","timestamp":1753203344000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Antibiotic resistance profiles and risk factors of multidrug-resistant Escherichia coli in a large tertiary care hospital in a low- and middle-income country"],"prefix":"10.1038","volume":"15","author":[{"given":"Nour","family":"Mousa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banan M.","family":"Aiesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruba","family":"Jomaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousef","family":"Zouneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraqat","family":"Namrouti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adham","family":"Abutaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samah W.","family":"Al-Jabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Sabateen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sa\u2019ed H.","family":"Zyoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,22]]},"reference":[{"key":"12384_CR1","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","volume":"404","author":"GBD 2021 Antimicrobial Resistance Collaborators","year":"2024","unstructured":"GBD 2021 Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance 1990\u20132021: a systematic analysis with forecasts to 2050. Lancet 404, 1199\u20131226. https:\/\/doi.org\/10.1016\/S0140-6736(24)01867-1 (2024).","journal-title":"Lancet"},{"key":"12384_CR2","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1016\/S0140-6736(22)02185-7","volume":"400","author":"GBD 2019 Antimicrobial Resistance Collaborators","year":"2022","unstructured":"GBD 2019 Antimicrobial Resistance Collaborators. Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the global burden of disease study 2019. Lancet 400, 2221\u20132248. https:\/\/doi.org\/10.1016\/S0140-6736(22)02185-7 (2022).","journal-title":"Lancet"},{"key":"12384_CR3","unstructured":"World Health Organization. Antimicrobial resistance. (2023). https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/antimicrobial-resistance (accessed December 6 2024)."},{"key":"12384_CR4","first-page":"298","volume":"7","author":"J Bishara","year":"2005","unstructured":"Bishara, J. et al. Antibacterial susceptibility of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli. Isr. Med. Assoc. J. 7, 298\u2013301 (2005).","journal-title":"Isr. Med. Assoc. J."},{"key":"12384_CR5","doi-asserted-by":"publisher","unstructured":"Caliskan-Aydogan, O. & Alocilja, E. C. A Review of Carbapenem Resistance in Enterobacterales and Its Detection Techniques. Microorganisms 11, (2023). https:\/\/doi.org\/10.3390\/microorganisms11061491","DOI":"10.3390\/microorganisms11061491"},{"key":"12384_CR6","doi-asserted-by":"publisher","first-page":"e27517","DOI":"10.5812\/jjm.27517","volume":"8","author":"AS Moini","year":"2015","unstructured":"Moini, A. S. et al. Multidrug-Resistant Escherichia coli and Klebsiella pneumoniae isolated from patients in kashan, Iran. Jundishapur J. Microbiol. 8, e27517. https:\/\/doi.org\/10.5812\/jjm.27517 (2015).","journal-title":"Jundishapur J. Microbiol."},{"key":"12384_CR7","doi-asserted-by":"publisher","first-page":"505","DOI":"10.4314\/ahs.v21i2.4","volume":"21","author":"KC Mofolorunsho","year":"2021","unstructured":"Mofolorunsho, K. C., Ocheni, H. O., Aminu, R. F., Omatola, C. A. & Olowonibi, O. O. Prevalence and antimicrobial susceptibility of extended-spectrum beta lactamases-producing Escherichia coli and Klebsiella pneumoniae isolated in selected hospitals of anyigba, Nigeria. Afr. Health Sci. 21, 505\u2013512. https:\/\/doi.org\/10.4314\/ahs.v21i2.4 (2021).","journal-title":"Afr. Health Sci."},{"key":"12384_CR8","doi-asserted-by":"publisher","first-page":"239","DOI":"10.5144\/0256-4947.2005.239","volume":"25","author":"AA Kader","year":"2005","unstructured":"Kader, A. A. & Kumar, A. Prevalence and antimicrobial susceptibility of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a general hospital. Ann. Saudi Med. 25, 239\u2013242. https:\/\/doi.org\/10.5144\/0256-4947.2005.239 (2005).","journal-title":"Ann. Saudi Med."},{"key":"12384_CR9","doi-asserted-by":"publisher","first-page":"189","DOI":"10.2147\/IDR.S391409","volume":"16","author":"EH Yoo","year":"2023","unstructured":"Yoo, E. H., Hong, H. L. & Kim, E. J. Epidemiology and mortality analysis related to Carbapenem-Resistant enterobacterales in patients after admission to intensive care units: an observational study. Infect. Drug Resist. 16, 189\u2013200. https:\/\/doi.org\/10.2147\/IDR.S391409 (2023).","journal-title":"Infect. Drug Resist."},{"key":"12384_CR10","unstructured":"Smith, H. Z., Hollingshead, C. M. & Kendall, B. In StatPearls (StatPearls Publishing,, 2025). Copyright \u00a9 2025, StatPearls Publishing LLC."},{"key":"12384_CR11","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos, A. P. et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin. Microbiol. Infect. 18, 268\u2013281. https:\/\/doi.org\/10.1111\/j.1469-0691.2011.03570.x (2012).","journal-title":"Clin. Microbiol. Infect."},{"issue":"Suppl 1","key":"12384_CR12","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/j.1469-0691.2007.01846.x","volume":"14","author":"L Drieux","year":"2008","unstructured":"Drieux, L., Brossier, F., Sougakoff, W. & Jarlier, V. Phenotypic detection of extended-spectrum beta-lactamase production in enterobacteriaceae: review and bench guide. Clin. Microbiol. Infect. 14 (Suppl 1), 90\u2013103. https:\/\/doi.org\/10.1111\/j.1469-0691.2007.01846.x (2008).","journal-title":"Clin. Microbiol. Infect."},{"key":"12384_CR13","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.1128\/JCM.00433-06","volume":"44","author":"T Spanu","year":"2006","unstructured":"Spanu, T. et al. Evaluation of the new VITEK 2 extended-spectrum beta-lactamase (ESBL) test for rapid detection of ESBL production in Enterobacteriaceae isolates. J. Clin. Microbiol. 44, 3257\u20133262. https:\/\/doi.org\/10.1128\/JCM.00433-06 (2006).","journal-title":"J. Clin. Microbiol."},{"key":"12384_CR14","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.mjafi.2021.03.026","volume":"79","author":"M Kumar","year":"2023","unstructured":"Kumar, M. et al. Rapid detection of carbapenem resistance among gram-negative organisms directly from positive blood culture bottles. Med. J. Armed Forces India. 79, 267\u2013274. https:\/\/doi.org\/10.1016\/j.mjafi.2021.03.026 (2023).","journal-title":"Med. J. Armed Forces India"},{"key":"12384_CR15","doi-asserted-by":"publisher","unstructured":"Chen, L., Jian, J., Xie, Z., Zhao, P. & Zhang, M. Isolation and Characterization of Carbapenem-Resistant Escherichia coli Carrying bla(NDM) and mcr-1 from Recurrent Urinary Tract Infection Patient. Can J Infect Dis Med Microbiol 6640009, (2023). https:\/\/doi.org\/10.1155\/2023\/6640009 (2023).","DOI":"10.1155\/2023\/6640009"},{"key":"12384_CR16","doi-asserted-by":"publisher","first-page":"687","DOI":"10.21608\/mid.2022.136762.1310","volume":"3","author":"M Meheissen","year":"2022","unstructured":"Meheissen, M. & Okasha, H. Verification of direct methods for detection of carbapenemase producing Enterobacteriaceae from blood cultures. Microbes Infect. Dis. 3, 687\u2013692. https:\/\/doi.org\/10.21608\/mid.2022.136762.1310 (2022).","journal-title":"Microbes Infect. Dis."},{"key":"12384_CR17","doi-asserted-by":"publisher","first-page":"DC08","DOI":"10.7860\/JCDR\/2015\/15672.6766","volume":"9","author":"M Kumar","year":"2015","unstructured":"Kumar, M., Dutta, R., Saxena, S. & Singhal, S. Risk factor analysis in clinical isolates of ESBL and MBL (Including NDM-1) producing Escherichia coli and Klebsiella species in a tertiary care hospital. J. Clin. Diagn. Res. 9, DC08\u201313. https:\/\/doi.org\/10.7860\/JCDR\/2015\/15672.6766 (2015).","journal-title":"J. Clin. Diagn. Res."},{"key":"12384_CR18","doi-asserted-by":"publisher","first-page":"3022","DOI":"10.1038\/s41598-024-53596-x","volume":"14","author":"BM Aiesh","year":"2024","unstructured":"Aiesh, B. M. et al. Epidemiology and clinical characteristics of patients with healthcare-acquired multidrug-resistant Gram-negative bacilli: a retrospective study from a tertiary care hospital. Sci. Rep. 14, 3022. https:\/\/doi.org\/10.1038\/s41598-024-53596-x (2024).","journal-title":"Sci. Rep."},{"key":"12384_CR19","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1086\/319757","volume":"32","author":"E Lautenbach","year":"2001","unstructured":"Lautenbach, E., Patel, J. B., Bilker, W. B., Edelstein, P. H. & Fishman, N. O. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin. Infect. Dis. 32, 1162\u20131171. https:\/\/doi.org\/10.1086\/319757 (2001).","journal-title":"Clin. Infect. Dis."},{"key":"12384_CR20","doi-asserted-by":"publisher","unstructured":"Batchoun, R. G., Swedan, S. F. & Shurman, A. M. Extended spectrum beta-Lactamases among Gram-Negative bacterial isolates from clinical specimens in three major hospitals in Northern Jordan. Int. J. Microbiol. 2009 (513874). https:\/\/doi.org\/10.1155\/2009\/513874 (2009).","DOI":"10.1155\/2009\/513874"},{"key":"12384_CR21","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s44337-024-00094-8","volume":"1","author":"M Almakrami","year":"2024","unstructured":"Almakrami, M. et al. Prevalence of multidrug-, extensively drug-, and pandrug-resistant bacteria in clinical isolates from King Khaled hospital, najran, Saudi Arabia. Discover Med. 1, 108. https:\/\/doi.org\/10.1007\/s44337-024-00094-8 (2024).","journal-title":"Discover Med."},{"key":"12384_CR22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1177\/2049936117727497","volume":"5","author":"S Patolia","year":"2018","unstructured":"Patolia, S., Abate, G., Patel, N., Patolia, S. & Frey, S. Risk factors and outcomes for multidrug-resistant Gram-negative bacilli bacteremia. Ther. Adv. Infect. Dis. 5, 11\u201318. https:\/\/doi.org\/10.1177\/2049936117727497 (2018).","journal-title":"Ther. Adv. Infect. Dis."},{"key":"12384_CR23","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3329\/bjm.v24i1.1231","volume":"24","author":"DJ Gomes","year":"1970","unstructured":"Gomes, D. J., Rahman, S. R. & Lina, T. T. Multiple-Antibiotic resistance mediated by plasmids and integrons in uropathogenic Escherichia coli and Klebsiella pneumoniae. Bangladesh J. Microbio. 24, 19\u201323. https:\/\/doi.org\/10.3329\/bjm.v24i1.1231 (1970).","journal-title":"Bangladesh J. Microbio"},{"key":"12384_CR24","doi-asserted-by":"crossref","unstructured":"Shalabi, M. et al. Antibiotic resistance of Escherichia coli in Jordan. PREPRINT (Version 1) available at Research Square   (2024).","DOI":"10.21203\/rs.3.rs-3861048\/v1"},{"key":"12384_CR25","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ijid.2019.04.004","volume":"83","author":"D Al Rahmany","year":"2019","unstructured":"Al Rahmany, D. et al. Exploring bacterial resistance in Northern oman, a foundation for implementing evidence-based antimicrobial stewardship program. Int. J. Infect. Dis. 83, 77\u201382. https:\/\/doi.org\/10.1016\/j.ijid.2019.04.004 (2019).","journal-title":"Int. J. Infect. Dis."},{"key":"12384_CR26","doi-asserted-by":"publisher","first-page":"635","DOI":"10.14740\/jocmr3928","volume":"11","author":"M Miyazaki","year":"2019","unstructured":"Miyazaki, M. et al. Change in the antimicrobial resistance profile of Extended-Spectrum beta-Lactamase-Producing Escherichia coli. J. Clin. Med. Res. 11, 635\u2013641. https:\/\/doi.org\/10.14740\/jocmr3928 (2019).","journal-title":"J. Clin. Med. Res."},{"key":"12384_CR27","first-page":"398","volume":"4","author":"MM Salem","year":"2010","unstructured":"Salem, M. M., Muharram, M., Alhosiny, I. M. & M. M. & Distribution of classes 1 and 2 integrons among multi drug resistant E. coli isolated from hospitalized patients with urinary tract infection in cairo, Egypt. Aust J. Basic. Appl. Sci. 4, 398\u2013407 (2010).","journal-title":"Aust J. Basic. Appl. Sci."},{"issue":"Suppl 1","key":"12384_CR28","doi-asserted-by":"publisher","first-page":"40","DOI":"10.4314\/ahs.v11i3.70069","volume":"11","author":"M Kibret","year":"2011","unstructured":"Kibret, M. & Abera, B. Antimicrobial susceptibility patterns of E. coli from clinical sources in Northeast Ethiopia. Afr. Health Sci. 11 (Suppl 1), 40\u201345. https:\/\/doi.org\/10.4314\/ahs.v11i3.70069 (2011).","journal-title":"Afr. Health Sci."},{"key":"12384_CR29","doi-asserted-by":"publisher","first-page":"368","DOI":"10.4314\/ahs.v12i3.19","volume":"12","author":"ME Ibrahim","year":"2012","unstructured":"Ibrahim, M. E., Bilal, N. E. & Hamid, M. E. Increased multi-drug resistant Escherichia coli from hospitals in Khartoum state, Sudan. Afr. Health Sci. 12, 368\u2013375. https:\/\/doi.org\/10.4314\/ahs.v12i3.19 (2012).","journal-title":"Afr. Health Sci."},{"key":"12384_CR30","first-page":"184","volume":"5","author":"Y Ngwai","year":"2010","unstructured":"Ngwai, Y. et al. Antimicrobial susceptibility of Escherichia coli and other coliforms isolated from urine of asymptomatic students in Bayelsa state, Nigeria. Afr. J. Microbiol. Res. 5, 184\u2013191 (2010).","journal-title":"Afr. J. Microbiol. Res."},{"key":"12384_CR31","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s10123-018-0006-1","volume":"21","author":"A Humayun","year":"2018","unstructured":"Humayun, A. et al. Incidence of metallo-beta-lactamase-producing Klebsiella pneumoniae isolates from hospital setting in Pakistan. Int. Microbiol. 21, 73\u201378. https:\/\/doi.org\/10.1007\/s10123-018-0006-1 (2018).","journal-title":"Int. Microbiol."},{"key":"12384_CR32","doi-asserted-by":"publisher","first-page":"3225","DOI":"10.2147\/IDR.S366808","volume":"15","author":"X Wang","year":"2022","unstructured":"Wang, X. et al. Mortality risk factors and prognostic analysis of patients with Multi-Drug resistant enterobacterales infection. Infect. Drug Resist. 15, 3225\u20133237. https:\/\/doi.org\/10.2147\/IDR.S366808 (2022).","journal-title":"Infect. Drug Resist."},{"key":"12384_CR33","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.2147\/IDR.S386311","volume":"16","author":"C Wu","year":"2023","unstructured":"Wu, C., Lu, J., Ruan, L. & Yao, J. Tracking epidemiological characteristics and risk factors of Multi-Drug resistant Bacteria in intensive care units. Infect. Drug Resist. 16, 1499\u20131509. https:\/\/doi.org\/10.2147\/IDR.S386311 (2023).","journal-title":"Infect. Drug Resist."},{"key":"12384_CR34","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.jiph.2016.08.007","volume":"10","author":"M Frieri","year":"2017","unstructured":"Frieri, M., Kumar, K. & Boutin, A. Antibiotic resistance. J. Infect. Public. Health. 10, 369\u2013378. https:\/\/doi.org\/10.1016\/j.jiph.2016.08.007 (2017).","journal-title":"J. Infect. Public. Health"},{"key":"12384_CR35","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.15537\/smj.2016.12.15739","volume":"37","author":"MM Alawi","year":"2016","unstructured":"Alawi, M. M. & Darwesh, B. M. A Stepwise introduction of a successful antimicrobial stewardship program. Experience from a tertiary care university hospital in western, Saudi Arabia. Saudi Med. J. 37, 1350\u20131358. https:\/\/doi.org\/10.15537\/smj.2016.12.15739 (2016).","journal-title":"Saudi Med. J."},{"key":"12384_CR36","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13756-019-0471-0","volume":"8","author":"D Nathwani","year":"2019","unstructured":"Nathwani, D. et al. Value of hospital antimicrobial stewardship programs [ASPs]: a systematic review. Antimicrob. Resist. Infect. Control. 8, 35. https:\/\/doi.org\/10.1186\/s13756-019-0471-0 (2019).","journal-title":"Antimicrob. Resist. Infect. Control"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12384-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12384-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12384-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T16:55:46Z","timestamp":1753203346000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12384-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,22]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["12384"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-12384-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,22]]},"assertion":[{"value":"20 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study protocol, which involved the use of patient clinical data, was approved by the Institutional Review Boards (IRBs) at An-Najah National University (Pharm.Sep.2022\/25). Permission to access patient records was also granted by An-Najah National University Hospital. Due to the retrospective nature of the study and the use of anonymized data, the IRB of An-Najah National University waived the need for informed consent. All research procedures adhered to the principles outlined in the Declaration of Helsinki and complied with relevant guidelines and regulations. Data confidentiality was rigorously maintained, with all information used solely for clinical research purposes. Identifiable data were replaced with numerical codes to ensure patient privacy.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"26667"}}